325 results on '"Ricci, Costantino"'
Search Results
52. Advantages of manual and automatic computer-aided compared to traditional histopathological diagnosis of melanoma: A pilot study
53. From histology to sonography in skin and superficial tissue disorders: EURO-MUSCULUS/USPRM* approach
54. SOX2 and PRAME in the “reprogramming” of seminoma cells
55. Trapezius Muscle and the Cutaneous Branches of Spinal Nerves: Sonographic/Anatomic Discussion of Myofascial Pain and Superficial Injections
56. Dysplastic nevi and melanoma: microRNAs tell a divergent story
57. Could double stain for p53/CK20 be a useful diagnostic tool for the appropriate classification of flat urothelial lesions?
58. Cutaneous Melanomas: A Single Center Experience on the Usage of Immunohistochemistry Applied for the Diagnosis
59. Female melanoma and estrogen receptors expression: an immunohistochemical pilot study
60. Interobserver agreement of PD-L1 (SP263) assessment in advanced NSCLC on cytological smears and histological samples
61. The EORTC protocol for sentinel lymph node biopsy (SLNB) reveals a high number of nodal nevi and a strong association with nevus-associated melanoma
62. Hematoxylin and eosin or double stain for CD34/SOX10: Which is better for the detection of lymphovascular invasion in cutaneous melanoma?
63. Trapezius Muscle and the Cutaneous Branches of Spinal Nerves: Sonographic/Anatomic Discussion of Myofascial Pain and Superficial Injections.
64. From histo-anatomy to sonography in lymphedema: EURO-MUSCULUS/USPRM approach
65. A case of adnexal tumor combining inverted follicular keratosis and trichoblastoma: molecular genetics evidence against a pathogenetic role of human Papillomaviruses
66. From Histoanatomy to Sonography in Myofascial Pain Syndrome
67. Mutational landscape in squamous cell carcinoma of the nail unit
68. Cutaneous composite lymphoma consisting of chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma: a unique entity and a putative pathological mechanism for cutaneous composite lymphomas
69. Low level of interobserver concordance in assessing histological subtype and tumor grade in patients with penile cancer may impair patient care
70. Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia In Situ, and Germ Cell Tumors of the Testis
71. NTRK Gene Fusion Detection in Atypical Spitz Tumors
72. Giant (pseudo) vascular spiradenoma: a case report of an extremely rare entity with the immuno-histological demonstration of the coexistence of vascular and pseudo-vascular components
73. A preliminary study investigating the detection of lymphovascular invasion in germ cell tumors of the testis with double staining for OCT4/CD34
74. HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME)
75. Abstract 2603: What's more in serrated lesions: interobserver agreement and molecular features
76. Basaloid follicular hamartomas in pediatric Basal Cell Nevus Syndrome: A diagnostic challenge
77. Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience
78. Could cathepsin-k be a driver of the myofibroblastic differentiation observed in dermatofibroma, atypical fibroxanthoma and pleomorphic dermal sarcoma?
79. Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia In Situ, and Germ Cell Tumors of the Testis.
80. Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing
81. Co-expression of Myoepithelial and Melanocytic Features in Carcinoma Ex Pleomorphic Adenoma
82. Cutaneous and Mucosal Melanomas of Uncommon Sites: Where Do We Stand Now?
83. Plaques und Tumoren unter der Therapie mit Mogamulizumab bei einer Patientin mit refraktärem Sézary-Syndrom
84. Pathological features and outcomes of incidental renal cell carcinoma in candidate solid organ donors
85. Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature
86. The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification
87. Next‐generation sequencing revealing TP53 mutation as potential genetic driver in dermal deep‐seated melanoma arising in giant congenital nevus in adult patients: A unique case report and review of the literature
88. Basal Cell Carcinoma: A Comprehensive Review
89. Sialadenoma Papilliferum of the Bronchus: A Rare Tumour of Salivary Gland Origin
90. Peculiar pathological, radiological and clinical features of skull‐base de‐differentiated chordomas. Results from a referral centre case–series and literature review
91. Eccrine angiokeratomatous hamartoma combined with solitary angiokeratoma or verrucous venous malformation: Report of two cases and comprehensive review of the literature
92. Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study
93. The tricky blue.
94. CORRELATION BETWEEN CLINICAL (Cl-R) AND PATHOLOGICAL RESPONSE (Pt-R) AFTER NEO-ADJUVANT ELECTROCHEMOTHERAPY (ECT) IN VULVAR SQUAMOUS CELL CARCINOMA(V-SCC)
95. Atypical fibroxanthoma associated with differentiated-type vulvar intraepithelial neoplasia: Case report of an unusual entity
96. Cutaneous composite lymphoma consisting of chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma: a unique entity and a putative pathological mechanism for cutaneous composite lymphomas
97. Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer
98. Plaques und Tumoren unter der Therapie mit Mogamulizumab bei einer Patientin mit refraktärem Sézary-Syndrom
99. Plaques and tumors in a patient with refractory Sézary syndrome treated with mogamulizumab
100. The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.